Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
dewey-ones:"330 - Economics"
Showing
1
-
20
of
111
Search:
''
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Cerliponase Alfa (Brineura -- Biomarin Pharmaceutical [Canada] Inc.) : indication : for the treatment of neuronal ceroid lipofu...
Published 2019
CADTH
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis
Published 2020
CADTH
Read Now
4
Pharmacoeconomic review report: Savuconazole (Cresemba) (AVIR pharma inc.)
Published 2019
CADTH
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Tofacinitib (Xeljanz) : indication: for the treatment of adult patients with moderately to severely active ulcerative colitis (...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Esketamine (Spravato -- Janssen inc.) : indication: for the treatment of major depressive disorder in adults
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
7
CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) : indication: chronic migraine
Published 2019
CADTH
Read Now
8
CADTH Canadian Drug Expert Committee recommendation: Indacaterol/Mometasone Furoate (Atectura Breezhaler -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma maintenance (...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Indacaterol/glycopyrronium/mometasone furoate (Enerzair Breezhaler -- Novartis Pharmaceuticals Canada Inc.) : indication: asthm...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Nintedanib (Ofev -- Boehringer Ingelheim Canada Inc.) : indication: chronic fibrosing interstitial lung diseases
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication: for the treatment of adult patients with moderately to severely activ...
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
15
CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic -- Ipsen Biopharmaceuticals Canada Inc.) : indication: for the symptomatic treatment of...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
16
CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
17
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
18
CADTH Canadian drug expert committee recommendation (final): Certolizumab pegol (Cimzia -- UCB Canada Inc.) : indication : treatment of adult patients with moderate-to severe plaqu...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
1
2
3
4
5
6
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Clear Filter
Classification: 330 - Economics
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
107
140 - Specific philosophical schools
13
700 - The arts; fine & decorative arts
8
Language
English
111
Collection
National Center for Biotechnology Information
111
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
68
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&type=AllFields
Send by Email
×
Loading...